This view is in line with the observation that either a loss of Smad424 or an elastase promoter-driven overexpression of transforming growth factor α (TGFα)25 in the PK model are essential for development of lesions similar to IPMN. Here, TGFA is linked to pancreatic intraductal papillary-mucinous neoplasm.